Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9

Jonathan Cohen, Alexander Pertsemlidis, Ingrid K. Kotowski, Randall Graham, Christine Kim Garcia, Helen H. Hobbs

Research output: Contribution to journalArticle

818 Citations (Scopus)

Abstract

The low-density lipoprotein receptor (LDLR) prevents hypercholesterolemia and atherosclerosis by removing low-density lipoprotein (LDL) from circulation. Mutations in the genes encoding either LDLR1 or its ligand (APOB)2 cause severe hypercholesterolemia. Missense mutations in PCSK9, encoding a serine protease in the secretory pathway3, also cause hypercholesterolemia4. These mutations are probably gain-of-function mutations, as overexpression of PCSK9 in the liver of mice produces hypercholesterolemia5-7 by reducing LDLR number. To test whether loss-of-function mutations in PCSK9 have the opposite effect, we sequenced the coding region of PCSK9 in 128 subjects (50% African American) with low plasma levels of LDL and found two nonsense mutations (Y142X and C679X). These mutations were common in African Americans (combined frequency, 2%) but rare in European Americans (<0.1%) and were associated with a 40% reduction in plasma levels of LDL cholesterol. These data indicate that common sequence variations have large effects on plasma cholesterol levels in selected populations.

Original languageEnglish (US)
Pages (from-to)161-165
Number of pages5
JournalNature Genetics
Volume37
Issue number2
DOIs
StatePublished - Feb 2005

Fingerprint

Nonsense Codon
LDL Cholesterol
Mutation
LDL Receptors
Hypercholesterolemia
LDL Lipoproteins
African Americans
Serine Proteases
Missense Mutation
Atherosclerosis
Cholesterol
Ligands
Liver
Population
Genes

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9. / Cohen, Jonathan; Pertsemlidis, Alexander; Kotowski, Ingrid K.; Graham, Randall; Garcia, Christine Kim; Hobbs, Helen H.

In: Nature Genetics, Vol. 37, No. 2, 02.2005, p. 161-165.

Research output: Contribution to journalArticle

@article{43bcd3139d7a40f192be9fa6fe3ffecc,
title = "Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9",
abstract = "The low-density lipoprotein receptor (LDLR) prevents hypercholesterolemia and atherosclerosis by removing low-density lipoprotein (LDL) from circulation. Mutations in the genes encoding either LDLR1 or its ligand (APOB)2 cause severe hypercholesterolemia. Missense mutations in PCSK9, encoding a serine protease in the secretory pathway3, also cause hypercholesterolemia4. These mutations are probably gain-of-function mutations, as overexpression of PCSK9 in the liver of mice produces hypercholesterolemia5-7 by reducing LDLR number. To test whether loss-of-function mutations in PCSK9 have the opposite effect, we sequenced the coding region of PCSK9 in 128 subjects (50{\%} African American) with low plasma levels of LDL and found two nonsense mutations (Y142X and C679X). These mutations were common in African Americans (combined frequency, 2{\%}) but rare in European Americans (<0.1{\%}) and were associated with a 40{\%} reduction in plasma levels of LDL cholesterol. These data indicate that common sequence variations have large effects on plasma cholesterol levels in selected populations.",
author = "Jonathan Cohen and Alexander Pertsemlidis and Kotowski, {Ingrid K.} and Randall Graham and Garcia, {Christine Kim} and Hobbs, {Helen H.}",
year = "2005",
month = "2",
doi = "10.1038/ng1509",
language = "English (US)",
volume = "37",
pages = "161--165",
journal = "Nature Genetics",
issn = "1061-4036",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9

AU - Cohen, Jonathan

AU - Pertsemlidis, Alexander

AU - Kotowski, Ingrid K.

AU - Graham, Randall

AU - Garcia, Christine Kim

AU - Hobbs, Helen H.

PY - 2005/2

Y1 - 2005/2

N2 - The low-density lipoprotein receptor (LDLR) prevents hypercholesterolemia and atherosclerosis by removing low-density lipoprotein (LDL) from circulation. Mutations in the genes encoding either LDLR1 or its ligand (APOB)2 cause severe hypercholesterolemia. Missense mutations in PCSK9, encoding a serine protease in the secretory pathway3, also cause hypercholesterolemia4. These mutations are probably gain-of-function mutations, as overexpression of PCSK9 in the liver of mice produces hypercholesterolemia5-7 by reducing LDLR number. To test whether loss-of-function mutations in PCSK9 have the opposite effect, we sequenced the coding region of PCSK9 in 128 subjects (50% African American) with low plasma levels of LDL and found two nonsense mutations (Y142X and C679X). These mutations were common in African Americans (combined frequency, 2%) but rare in European Americans (<0.1%) and were associated with a 40% reduction in plasma levels of LDL cholesterol. These data indicate that common sequence variations have large effects on plasma cholesterol levels in selected populations.

AB - The low-density lipoprotein receptor (LDLR) prevents hypercholesterolemia and atherosclerosis by removing low-density lipoprotein (LDL) from circulation. Mutations in the genes encoding either LDLR1 or its ligand (APOB)2 cause severe hypercholesterolemia. Missense mutations in PCSK9, encoding a serine protease in the secretory pathway3, also cause hypercholesterolemia4. These mutations are probably gain-of-function mutations, as overexpression of PCSK9 in the liver of mice produces hypercholesterolemia5-7 by reducing LDLR number. To test whether loss-of-function mutations in PCSK9 have the opposite effect, we sequenced the coding region of PCSK9 in 128 subjects (50% African American) with low plasma levels of LDL and found two nonsense mutations (Y142X and C679X). These mutations were common in African Americans (combined frequency, 2%) but rare in European Americans (<0.1%) and were associated with a 40% reduction in plasma levels of LDL cholesterol. These data indicate that common sequence variations have large effects on plasma cholesterol levels in selected populations.

UR - http://www.scopus.com/inward/record.url?scp=13944265645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13944265645&partnerID=8YFLogxK

U2 - 10.1038/ng1509

DO - 10.1038/ng1509

M3 - Article

VL - 37

SP - 161

EP - 165

JO - Nature Genetics

JF - Nature Genetics

SN - 1061-4036

IS - 2

ER -